In the Boston area, three months into the new year, the mood in the biotech industry has soured and the outlook has clouded.

Assetmark Inc. lowered its position in Genmab A/S (NASDAQ:GMAB – Free Report) by 78.1% during the fourth quarter, Holdings ...

AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.

Bullish option flow detected in Teva (TEVA) with 17,095 calls trading, 1.7x expected, and implied vol increasing over 1 point to 42.32%. 3/14 ...

PNC Financial Services reduced its holdings in Regeneron Pharmaceuticals by 8.8% in the fourth quarter, selling 1,608 shares. Other institutional investors have also adjusted their positions, with ...

OFI Invest Asset Management purchased 5,674 shares of Amgen, valued at $1.43 million. Other hedge funds, including Swedbank ...